New cancer clinical trial: Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer

Published on: November 30, 2018 at 12:00PM
Condition:   Bladder Cancer
Intervention:   Biological: Durvalumab
Sponsor:   Hellenic GenitoUrinary Cancer Group
Recruiting
https://ift.tt/2QwO6ji